DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Di Leo A, Bleiberg H, Buyse M.
Overall survival is not a realistic end point for clinical trials of new drugs in advanced solid tumors: a critical assessment based on recently reported phase III trials in colorectal and breast cancer.
J Clin Oncol 2003; 21: 2045-2047
We do not assume any responsibility for the contents of the web pages of other providers.